192 related articles for article (PubMed ID: 1446861)
1. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
[TBL] [Abstract][Full Text] [Related]
2. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.
Esteve-Comas M; Núñez MC; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Bertrán X; Gassull MA
Gut; 1993 Oct; 34(10):1370-3. PubMed ID: 8244103
[TBL] [Abstract][Full Text] [Related]
3. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease.
Kuroki F; Iida M; Matsumoto T; Aoyagi K; Kanamoto K; Fujishima M
Dig Dis Sci; 1997 Jun; 42(6):1137-41. PubMed ID: 9201073
[TBL] [Abstract][Full Text] [Related]
4. Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.
Fernández-Bañares F; Esteve-Comas M; Mañé J; Navarro E; Bertrán X; Cabré E; Bartolí R; Boix J; Pastor C; Gassull MA
Clin Nutr; 1997 Aug; 16(4):177-83. PubMed ID: 16844596
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.
Kiasat A; Rautiainen S; Prast-Nielsen S; Engstrand L; Schuppe-Koistinen I; Gustafsson UO; Löf Granström A
Scand J Gastroenterol; 2023; 58(11):1246-1252. PubMed ID: 37272725
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
7. Determinants of plasma Fatty Acid abnormalities in patients with active inflammatory bowel disease: a multivariate analysis.
Esteve-Comas M; Ramirez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Bertrán X; Gassull MA
Inflamm Bowel Dis; 1995; 1(2):95-100. PubMed ID: 23282301
[TBL] [Abstract][Full Text] [Related]
8. Adhesion molecules in inflammatory bowel disease.
Jones SC; Banks RE; Haidar A; Gearing AJ; Hemingway IK; Ibbotson SH; Dixon MF; Axon AT
Gut; 1995 May; 36(5):724-30. PubMed ID: 7541009
[TBL] [Abstract][Full Text] [Related]
9. Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease.
Schmedes A; Nielsen JN; Hey H; Brandslund I
Clin Chem Lab Med; 2004; 42(6):648-53. PubMed ID: 15259382
[TBL] [Abstract][Full Text] [Related]
10. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
12. Plasma viscosity in inflammatory bowel disease.
Lobo AJ; Jones SC; Juby LD; Axon AT
J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
[TBL] [Abstract][Full Text] [Related]
13. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
Nielsen OH; Brynskov J; Bendtzen K
Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
[TBL] [Abstract][Full Text] [Related]
14. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease.
Pacheco S; Hillier K; Smith C
Clin Sci (Lond); 1987 Oct; 73(4):361-4. PubMed ID: 3665357
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
Gilman J; Shanahan F; Cashman KD
Aliment Pharmacol Ther; 2006 Apr; 23(7):1007-16. PubMed ID: 16573803
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
[TBL] [Abstract][Full Text] [Related]
17. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease.
Ueda Y; Kawakami Y; Kunii D; Okada H; Azuma M; Le DS; Yamamoto S
Nutr Res; 2008 Apr; 28(4):239-44. PubMed ID: 19083414
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine in patients with inflammatory bowel diseases.
Owczarek D; Cibor D; Sałapa K; Jurczyszyn A; Mach T
Przegl Lek; 2014; 71(4):189-92. PubMed ID: 25141576
[TBL] [Abstract][Full Text] [Related]
19. Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study.
Grimstad T; Berge RK; Bohov P; Skorve J; Gøransson L; Omdal R; Aasprong OG; Haugen M; Meltzer HM; Hausken T
Scand J Clin Lab Invest; 2011 Feb; 71(1):68-73. PubMed ID: 21142420
[TBL] [Abstract][Full Text] [Related]
20. Antioxidative Efficacy of a
Papada E; Forbes A; Amerikanou C; Torović L; Kalogeropoulos N; Tzavara C; Triantafillidis JK; Kaliora AC
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
